Skip to main content

Radio Frequency Ablation (RFA) Program for Benign Tumors

May 24, 2021

The Division of Endocrinology, Metabolism and Diabetes and Huntsman Cancer Institute would like to introduce the newly established radio-frequency ablation (RFA) program for the treatment of thyroid tumors. RFA is a minimally invasive alternative therapy to surgery for in-situ destruction of benign thyroid nodules and some thyroid carcinomas. 

Dr. Dev Abraham will be directing this program after having received training at the Asan Medical Center in Seoul, South Korea, under the guidance of Dr. Jung Hwan BaekDr. Baek, a leading authority in this field, refined the application of RFA for thyroid tumors. This outpatient procedure is conducted under local anesthesia in lieu of surgery. 

Please contact Dr. Abraham directly with any questions regarding this procedure. For new patient referrals, please contact Dr. Abraham directly at dev.abraham@hsc.utah.edu, by sending a MyChart message or by paging using smart-web system. You can also reach his medical assistant, Mrs. Carolina Tamayo, by calling UDEC at 801-581-7761 or HCI Clinic 1A at 801-213-4266. Please leave a message so your call can be returned.